Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.57 |
| ▸ | DRD4 | P21917 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30167657 | 1.00 | DRD2 (0.57) | DRD2DRD4KMT2ADRD3TDP1 | |
| Ammonia Solution, Strong SCHEMBL9124747 | 0.98 | DRD2 (0.56) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL3894255 | 0.90 | DRD2 (0.63) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL29381067 | 0.89 | DRD2 (0.62) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL27465 | 0.89 | DRD2 (0.62) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL23267298 | 0.89 | MAPK1 (0.61) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL12206636 | 0.89 | MAPK1 (0.61) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL17214432 | 0.89 | MAPK1 (0.61) | DRD2DRD4KMT2ADRD3TDP1 | |
| SCHEMBL12301114 | 0.88 | TSHR (0.64) | DRD2DRD4DRD3TDP1L3MBTL1 | |
| SCHEMBL11674802 | 0.87 | DRD2 (0.66) | DRD2DRD4KMT2ADRD3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858907-B2 | Kinase modulators | RHIZEN PHARMACEUTICALS AG (CH) | 2024-01-02 | — | — | US | disclosed |
| US-11858907-B2 | Kinase modulators | RHIZEN PHARMACEUTICALS AG (CH) | 2024-01-02 | — | — | US | disclosed |
| WO-2023224029-A1 | SARS-COV-2 INHIBITOR | 国立大学法人東海国立大学機構 | 2023-11-23 | — | — | WO | disclosed |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | GENENTECH, INC. (US) | 2023-08-24 | — | — | US | disclosed |
| US-20230183286-A1 | NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA | NOVARTIS AG (CH) | 2023-06-15 | — | — | US | disclosed |
| US-20230183286-A1 | NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA | NOVARTIS AG (CH) | 2023-06-15 | — | — | US | disclosed |
| US-20230152695-A1 | RESIST UNDERLAYER FILM MATERIAL, PATTERNING PROCESS, AND METHOD FOR FORMING RESIST UNDERLAYER FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230151159-A1 | COMPOUND FOR FORMING HARDMASK, HARDMASK COMPOSITION INCLUDING THE COMPOUND, AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE HARDMASK COMPOSITION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-5679856-A | OXYBROMINATION OF A PHENOL ETHER COMPOUND USING ELEMENTAL BROMINE IN THE PRESENCE OF HYDROGEN PEROXIDE AND A CATALYST; REACTING WITH FORMANILIDE | CIBA-GEIGY CORPORATION (US) | 1997-10-21 | — | — | US | disclosed |
| US-5563159-A | Dithiocarbonimide derivatives useful as acaricidal, fungicidal, and insecticidal agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-10-08 | — | — | US | disclosed |
| EP-0727411-A2 | Process for the preparation of diphenylamines | CIBA-GEIGY AG (CH) | 1996-08-21 | — | — | EP | disclosed |
| CN-1007153-B | PREPN. OF BENZOTHIOPHENES AND BENZOFURANS HAVING ANTIALLERGY ACTIVITY | WARNER LAMBERT CO (US) | 1990-03-14 | — | — | CN | disclosed |
| CN-85109587-A | Have the new benzothiophene kind of antiallergic activity and the preparation method of benzofuran compounds | — | 1986-12-17 | — | — | CN | disclosed |
| US-4393241-A | Synthesis of alkoxy and phenoxy substituted aryl sulfides | CELANESE CORPORATION (US) | 1983-07-12 | — | — | US | disclosed |
| US-4354904-A | Electrochemical oxidation of alkyl aromatic compounds | UOP INC. (US) | 1982-10-19 | — | — | US | disclosed |
| US-4212711-A | Electrochemical oxidation of alkyl aromatic compounds | UOP INC. (US) | 1980-07-15 | — | — | US | disclosed |
| US-4212710-A | Electrochemical oxidation of alkyl aromatic compounds | UOP INC. (US) | 1980-07-15 | — | — | US | disclosed |
| US-4148696-A | Electrochemical oxidation of activated alkyl aromatic compounds | UOP INC. (US) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183286-A1 | NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA | RNGTT, NSUN2, NSUN3 | DRD2 4125/4885DRD4 3221/4885KMT2A 1755/4885 |
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | SHH, GLI1, SMO | DRD2 3308/4885DRD4 3430/4885KMT2A 1528/4885 |
| US-11858907-B2 | Kinase modulators | RPS6KA1, RPS6KA2, PRKAR2A | DRD2 4750/4885DRD4 4840/4885KMT2A 3863/4885 |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | DRD2 2745/4885DRD4 2506/4885KMT2A 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.